We hypothesized that if expression of RGS proteins is decreased in ovarian cancer cells, this may amplify tonic constitutive LPA-stimulated cell survival pathways, allowing cells to overcome cytotoxicity. This evidence concerns the gene PITX2 and ovarian carcinoma.